Challenge

Grünenthal faced complex regulatory requirements for entering the Kenyan pharmaceutical market with their branded generic products. The Pharmacy and Poisons Board had stringent registration processes, and maintaining compliance for pain management and specialty pharmaceutical products required deep local expertise and continuous monitoring of regulatory changes.

Solution

ECP provided end-to-end regulatory consulting services, including product registration management, compliance strategy development, and ongoing regulatory maintenance. Our team facilitated communication with regulatory authorities, developed tailored strategies for Grünenthal's portfolio, and established systems for continuous compliance monitoring and stakeholder engagement.

Results

The partnership resulted in successful market entry and sustainable operations in Kenya. Multiple branded generic products were registered, a robust compliance framework was established, and Grünenthal achieved their strategic objectives in the East African market. The project showcased ECP's expertise in supporting global pharmaceutical companies navigate complex regulatory environments.

• Successful registration of multiple branded generic products
• Established comprehensive regulatory compliance systems
• Enhanced stakeholder relationships with Kenyan authorities
• Sustained market presence and business continuity